In 2014, Giorgos Tsetis co-founded Nutrafol to address hair growth after experiencing hair loss in his 20s. He sold his remaining equity in the company earlier this year, valuing it at $3.5 billion, and stepped down as CEO. Tsetis aims to invest in companies that promote social good and leave a better world for his children.

Tsetis established his family office, Great Things, to use investment profits for philanthropy. He joins a group of ultra-wealthy millennials setting up family offices to support causes like sustainability. Tsetis prioritizes impact investing and involving his children in the process to create positive change in the world.

Great Things has a for-profit and nonprofit arm, with a focus on using investment returns to fund charities supporting mental health and crisis response. Tsetis expanded his startup investments after Nutrafol’s Series B funding and focuses on AI-driven companies in healthcare, like NewLimit and BreakBio.

Tsetis has concerns about the impact of AI but believes early-stage investing allows him to influence the future. He aims to prioritize human well-being and give his portfolio companies a say in how investment returns are donated. Great Things has supported nonprofits like Every Cure and Ubuntu Pathways.

Tsetis encourages other investors to prioritize social responsibility and hopes more people will take action against wealth concentration. He envisions a future where investing in causes and giving back is a primary focus rather than an afterthought. Tsetis and his family office, Great Things, are dedicated to making a positive impact on the world.

Read more at CNBC: Investing in AI, health tech